%0 Journal Article
%T Gadolinium Deposition in Neurology Clinical Practice
%A Andrew Steven
%A Bridget A. Bagert
%A Tyler E. Smith
%J Archive of "The Ochsner Journal".
%D 2019
%R 10.31486/toj.18.0111
%X Background: Magnetic resonance imaging (MRI) enhanced with gadolinium-based contrast agents (GBCAs) is an essential tool in the diagnosis and management of many neurologic diseases, including multiple sclerosis, brain tumors, and infections. The clinical utility of GBCAs is evidenced by their widespread use. GBCAs are produced in macrocyclic and linear forms. Since 2014, evidence has suggested that repeated administration of GBCAs can lead to gadolinium deposition in the brain
%K Contrast media
%K gadolinium
%K magnetic resonance imaging
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447198/